Ajay Devgn Moves High Court Against Tukaram Mundhe's Notice Over 'Vimal Elaichi' Ads
Source Entity
NDTV News Search Records Found 1000
Ajay Devgn has petitioned the Bombay High Court to challenge Maharashtra FDA show-cause notices regarding 'Vimal Elaichi' advertisements. The FDA alleges these ads serve as surrogate promotion for banned pan masala products, naming Shah Rukh Khan and Tiger Shroff as well.
Legal Confrontation: Bollywood Stars vs. Maharashtra FDA
Bollywood superstar Ajay Devgn has initiated formal legal proceedings in the Bombay High Court to contest show-cause notices issued by the Maharashtra Food and Drug Administration (FDA). The controversy centers on advertisements for 'Vimal Elaichi,' which the FDA alleges act as a 'surrogate' marketing mechanism for 'Vimal Pan Masala,' a product categorized as a prohibited smokeless tobacco item within the state. This legal challenge marks a significant escalation in the ongoing tension between regulatory authorities and high-profile celebrities regarding the promotion of potentially harmful consumer goods.
The Core of the Legal Dispute
The fundamental argument presented in Devgn's petition is that the FDA's decision to target him individually is arbitrary. Devgn contends that as an actor, he is a participant in a commercial engagement and that the regulatory focus should be directed primarily at the manufacturing company responsible for the product's marketing strategy. By moving the court, Devgn is seeking to challenge the validity of the notice, which requires him to explain his endorsement agreements and potentially withdraw the advertisements from public view.
Broadening Scope: Khan and Shroff Under Scrutiny
Ajay Devgn is not the only celebrity caught in this regulatory crossfire. The Maharashtra FDA has extended its scrutiny to other prominent actors, specifically Shah Rukh Khan and Tiger Shroff, who have also featured in the same advertising campaigns. FDA Commissioner Tukaram Mundhe confirmed that while all three actors initially responded to the show-cause notices and requested hearings, the situation has now progressed to an adjudication phase. The involvement of multiple A-list celebrities underscores the high stakes involved in the regulation of surrogate advertising for tobacco products.
The Surrogate Advertising Dilemma
Surrogate advertising remains a contentious issue in Indian consumer law. Companies often promote a non-tobacco product—such as mouth fresheners or elaichi—using the same brand name and aesthetic associated with their banned tobacco products to maintain brand recall among consumers. The FDA’s stance is that these 'Vimal Elaichi' ads are merely a facade for the banned 'Vimal Pan Masala.' This case highlights the difficulty regulators face in distinguishing between legitimate product endorsements and strategic attempts to bypass public health prohibitions.
Judicial Intervention and Future Trends
A division bench of the Bombay High Court, led by Chief Justice Mahesh Chandra Tripathi and Justice Advait Sethna, is scheduled to hear Devgn’s petition on November 4. The outcome of this hearing is expected to set a critical precedent for how Indian courts view individual liability in celebrity endorsements. If the court sides with the actors, it could force regulators to pivot toward stricter oversight of parent manufacturing companies. Conversely, a ruling in favor of the FDA could lead to a significant chilling effect on the endorsement industry, forcing brands and celebrities to reconsider their associations with products that tread the line of regulatory compliance.
Multiple Citing Sources
Verification Required?